https://wellthytherapeutics.com/*The pace of change in Healthcare*Primary, the technological development making available ever-greater amounts of data from which advanced analytics can mine insights, has enabled the proliferation of personalized hardware, particularly smartphones and wearable. Second, is the growing body of evidence that digital interventions have generated. Peer-reviewed studies show improved outcomes from digital therapeutics, either alone or in conjunction with conventional protocols, in a broad range of indications, including Oncology, T2DM, Asthma, Schizophrenia alongside partnering with Pharmaceuticals, Medical device players, Health insurance & Hospitals/Clinics. These companies are seeking to develop digital solutions inform of DTx that improve current therapies and foster new ones. And the US Food and Drug Administration (FDA), keen to encourage digital innovation in healthcare, is evolving the regulatory framework accordingly.

The reserach & Diagnostics market grows as advancement in technology increases. Roche is a pioneer in state of art technology and a leader in Diagnostics market. Dealing with such a cutting edge technology in molecular biology which includes the Real Time PCRs & the sequencers for high end research labs & Biotech companies.

Was involved in project of Virtual Proteomics and also docking experiments for a drug. Also understood the wet lab experiments related to Genomics & Proteomics

Worked on insilico techniques for drug designing. The techniques mainly include Molecular Docking, De novo model building, Homology Modelling, Pharmacophore modelling, QSAR studies etc.

In BAT, I had made a database for Pancreatic Cancer using SQL server and the GUI was designed on the .NET platform using C#. A list of 120 genes where included along with their molecular and functional level information. A comprehensive database was built which was crossed linked to public databases for more connectivity.